There are two main categories of healthcare data used to cull insights that drive Life Sciences’ decision-making: “open” and “closed.”
Historically, teams across the product life cycle have chosen to work with one over the other, depending on their roles. Commercial experts, for example, have leveraged data from open claims and other sources that could provide directional guidance without delay, enabling them to remain agile in highly competitive markets. Conversely, research teams that are focused on evidence generation and healthcare resource utilization have preferred to work exclusively with closed claims data because of its completeness.
But as the healthcare market has evolved, so have legacy practices. Increasingly, teams are using both types of data to maximize insight generation and increase confidence in their decision-making. You can, too.
To see more articles like this, follow Komodo Health on X, LinkedIn, or YouTube, and visit Insights on our website.
